Virtual Public Discussion – Public Health and Pharmaceutical Views of the COVID-19 Pandemic

The global outbreak of the novel coronavirus has led to the deaths of hundreds and thousands of lives globally. Currently, stay-at-home practices are the best way of curbing the number of infections. Finding a vaccine is ultimately the number one weapon to fight this pandemic. 

Dr. Anthony S. Fauci, the top infectious disease expert on the Trump administration’s coronavirus task force, estimated that it would take at least 12 to 18 months for a vaccine to arrive. According to the World Health Organization (WHO) Draft Landscape of COVID-19 Candidate Vaccines report, there are currently 110 vaccines being developed worldwide and eight undergoing clinical trials.

In the meantime, shortages of health equipment such as face masks, ventilators, and protective gears as well as insufficient number of referral hospitals available demonstrates that Indonesia cannot keep up with the rapid growth of Coronavirus spreading throughout the region. 

This virtual public discussion will address circulating concerns of pandemic response both from public health and pharmaceutical perspectives. What does the race to find COVID-19 vaccine in Indonesia look like? When a vaccine finally does arrive, how can we ensure that it is made accessible and affordable for those who need it most? Until then, what can we do to ease pressure off deteriorating public health? 

Foreign Policy Community of Indonesia (FPCI) would like to invite you watch our Virtual Public Discussion titled ”Public Health and Pharmaceutical Views of the COVID-19 Pandemic”


  1. Dr. Claudia Surjadjaja, Regional Director Asia at World Mosquito Program
  2. Bernadette Ruth Irawati Setiady, Chairwoman of PT. Kalbe Farma Tbk.
  3. Dr. Paranietharan (Paranie), WHO Country Representative to Indonesia

Moderator: Donny Agustiady, Director of PwC Indonesia

Recommended Posts